Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human heterologous liver cells (for infusion)

EU orphan designation number: EU/3/07/470   
Active ingredient: Human heterologous liver cells (for infusion)
Indication: Treatment of ornithine-transcarbamylase deficiency
Sponsor: Promethera Biosciences
Watson & Crick Hill, 11 Rue Granbonpré, B-1435 Mont-Saint-Guibert, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Orphan designation EMEA/OD/042/07 (2007)4331 of 14/09/2007
20/06/2016 Transfer of orphan designation EMA/OD/042/07/T/01 (2016)3848 of 16/06/2016